المؤلفون: Cabrero, D.S., Cruz, P., de Castro, J., Higuera, O., Pertejo, A., Esteban, I., Gutierrez, L., Villamayor, J., Ostios, L., Viñal, D., Miranda, J.

المصدر: Annals of Oncology ; volume 30, page ii75 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdz065.003
https://api.elsevier.com/content/article/PII:S0923753419301565?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419301565?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/30/Supplement_2/mdz065.003/28355580/mdz065.003.pdf

المؤلفون: Lamarca, Angela, Ostios, L, McNamara, Mairead G, Garzon, C, Gleeson, Jack P, Edeline, J, Herrero, A, Hubner, Richard A, Moreno, V, Valle, John W

المساهمون: Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom

Relation: https://dx.doi.org/10.1016/j.ctrv.2023.102627; Lamarca A, Ostios L, McNamara MG, Garzon C, Gleeson JP, Edeline J, et al. Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma. Cancer Treat Rev. 2023 Sep 16;121:102627. PubMed PMID: 37925878. Epub 2023/11/06. eng.; http://hdl.handle.net/10541/626766; Cancer Treatment Reviews

الاتاحة: http://hdl.handle.net/10541/626766
https://doi.org/10.1016/j.ctrv.2023.102627

المؤلفون: Pacheco-Barcia, V., Hernandez Sangil, R., Fernández Montes, A., Cruz Castellanos, P., Castillo Trujillo, A., Rogado, J., Antoñanzas, M., Gil Raga, M., Manzano, A., Asensio, H., Lorente, D., Obispo, B., Ostios, L., López de Ceballos, M., Valero Arbizu, M., García Carrasco, M., Maria Cano, J., Piera, N., Carmona-Bayonas, A., García, T., Calderón, C.

المصدر: Annals of Oncology ; volume 32, page S157 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2021.05.223
https://api.elsevier.com/content/article/PII:S0923753421014125?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753421014125?httpAccept=text/plain

المؤلفون: Viñal, D., Gutierrez-Sainz, L., Martinez, D., Garcia-Cuesta, J. A., Pedregosa, J., Villamayor, J., Ostios, L., Sanchez-Cabrero, D., Higuera, O., Pinto, A., Rodriguez-Salas, N., Espinosa, E., de Castro, J., Feliu, J.

المصدر: Clinical and Translational Oncology ; volume 23, issue 6, page 1185-1192 ; ISSN 1699-048X 1699-3055

الاتاحة: http://dx.doi.org/10.1007/s12094-020-02509-1
https://link.springer.com/content/pdf/10.1007/s12094-020-02509-1.pdf
https://link.springer.com/article/10.1007/s12094-020-02509-1/fulltext.html

المؤلفون: Castelo, B., Viñal, D., Maseda, R., Ostios, L., Sánchez, D., García-Salvatierra, B., Escámez, M. J., Martínez-Santamaría, L., Del Río, M., Mora-Rillo, M., Vilches, Y., Beato, M. J., López Gutiérrez, J. C., Romero, N., Santos, C., Miranda, J., de Lucas, R.

المصدر: Clinical and Translational Oncology ; volume 21, issue 11, page 1573-1577 ; ISSN 1699-048X 1699-3055

الاتاحة: http://dx.doi.org/10.1007/s12094-019-02073-3
http://link.springer.com/content/pdf/10.1007/s12094-019-02073-3.pdf
http://link.springer.com/article/10.1007/s12094-019-02073-3/fulltext.html

المؤلفون: Viñal, D., Gutierrez-Sainz, L., Martinez, D., Garcia-Cuesta, J. A., Pedregosa, J., Villamayor, J., Ostios, L., Sanchez-Cabrero, D., Higuera, O., Pinto, A., Rodriguez-Salas, N., Espinosa, E., de Castro, J., Feliu, J.

المصدر: Clinical & Translational Oncology; Jun2021, Vol. 23 Issue 6, p1185-1192, 8p

المؤلفون: D errico G, Miranda J, Ostios L, Villamayor J

المصدر: Immunology Case Reports.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, Ipilimumab, Pembrolizumab, Immunotherapy, medicine.disease, Cancer immunotherapy, Atezolizumab, Internal medicine, Immunology, medicine, Nivolumab, business, Adverse effect, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a11efc8aac98221bf561869f6c4107f1
https://doi.org/10.35841/immunology-case-reports.1.2.31-35